Influence of wall motion score on mortality after coronary bypass surgery in the CABG-patch trial

International Journal of Cardiology - Tập 82 - Trang 41-47 - 2002
Frank Jung1,2, John M Herre3, Mark A Wood4, Susan O’Donoghue5, David S Cannom6, John R Windle7, Thomas Hilbel8, Deepak R Talreja9, Michael K Parides10, J.Thomas Bigger10, John P DiMarco1
1Electrophysiology Laboratory, Cardiovascular Division, Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA
2Johann-Wolfgang-Goethe-Universität, Frankfurt/Main, Germany
3DePaul Hospital, Norfolk, Va., USA
4Medical College of Virginia, Richmond, VA, USA
5Washington Hospital Center, Washington, DC USA
6Hospital of the Good Samaritan, Los Angeles, CA, USA
7University of Nebraska Medical Center, Omaha, NE., USA
8Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
9Vanderbilt University Medical Center, Nashville, TN, USA
10Columbia University, New York, NY, USA

Tài liệu tham khảo

Risum, 1996, Mortality and morbidity after coronary artery bypass surgery related to pre-operative left ventricular ejection fraction: a follow-up study, Eur Heart J, 17, 874, 10.1093/oxfordjournals.eurheartj.a014968 Risum, 1995, Risk factors for early and late mortality in surgical treatment of coronary artery disease, Cardiovasc Surg, 3, 537, 10.1016/0967-2109(95)94455-6 Bigger, 1997, Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators, New Engl J Med, 337, 1569, 10.1056/NEJM199711273372201 Passamani, 1985, A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction, New Engl J Med, 312, 1665, 10.1056/NEJM198506273122603 Freeman, 1984, Early and long-term results of coronary artery bypass grafting with severely depressed left ventricular performance, Am J Cardiol, 54, 749, 10.1016/S0002-9149(84)80202-7 Nath, 1993, Use of a regional wall motion score to enhance risk stratification of patients receiving an implantable cardioverter-defibrillator, J Am Coll Cardiol, 22, 1093, 10.1016/0735-1097(93)90421-V Nath, 1993, Regional wall motion analysis predicts survival and functional outcome after subendocardial resection in patients with prior anterior myocardial infarction, Circulation, 88, 70, 10.1161/01.CIR.88.1.70 Nath, 1993, Comparison of the usefulness of the implantable cardioverter-defibrillator and subendocardial resection in patients with sustained ventricular arrhythmias and poor regional wall motion associated with coronary artery disease, Am J Cardiol, 72, 652, 10.1016/0002-9149(93)90879-H Spotnitz, 1998, Effect of implantable cardioverter-defibrillator implantation on surgical morbidity in the CABG Patch Trial. Surgical Investigators of the Coronary Artery Bypass Graft Patch Trial, Circulation, 98, II77 Curtis, 1997, Baseline characteristics of patients in the Coronary Artery Bypass Graft (CABG) Patch Trial, Am Heart J, 134, 787, 10.1016/S0002-8703(97)80001-4 Sandler, 1968, The use of single plane angiocardiograms for the calculation of left ventricular volume in man, Am Heart J, 75, 325, 10.1016/0002-8703(68)90089-6 Kennedy, 1970, Left ventricular volume and mass from single-plane cineangiocardiogram. A comparison of anteroposterior and right anterior oblique methods, Am Heart J, 80, 343, 10.1016/0002-8703(70)90099-2 Sheehan, 1986, Advantages and applications of the centerline method for characterizing regional ventricular function, Circulation, 74, 293, 10.1161/01.CIR.74.2.293 Bigger, 1999, Mechanism of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery, Circulation, 99, 1416, 10.1161/01.CIR.99.11.1416 Kennedy, 1991, Clinical and angiographic predictors of operative mortality from the Collaborative Study in the Coronary Artery Surgery Study (CASS), Circulation, 83, 1125 Olshansky B, Telfer EA, Rolnitzky L, Bigger JT for the CABG Patch Trial Investigators. The CABG Patch Trial: does ejection fraction predict mortality and complications in high risk patients after bypass graft surgery (abstr). Circulation 1997;96:I-91. Kron IL, Flanagan TL, Blackbourne LH et al. Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. Ann Surg 1989;210:348–352; discussion 352–354. Elefteriades, 1995, CABG in advanced left ventricular dysfunction, Cardiol Clin, 13, 35, 10.1016/S0733-8651(18)30060-2 Elefteriades, 1997, Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fractions < or =30%, Am J Cardiol, 79, 1573, 10.1016/S0002-9149(97)00201-4 Elefteriades, 1993, Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state, J Am Coll Cardiol, 22, 1411, 10.1016/0735-1097(93)90551-B Kawachi, 1997, Increased risk of coronary artery bypass grafting for left ventricular dysfunction with dilated left ventricle, J Cardiovasc Surg (Torino), 38, 501 Huikuri, 1992, Clinical and angiographic prediction of cardiac death after coronary artery bypass graft surgery, Br Heart J, 67, 216, 10.1136/hrt.67.3.216 Sergeant, 1986, Is the outcome of coronary artery bypass graft surgery predictable in patients with severe ventricular function impairment?, J Cardiovasc Surg (Torino), 27, 618 Sergeant, 1987, The value of ejection fraction as a predictor of early and late survival following aortocoronary bypass surgery in patients with moderate to severe depression of the left ventricular function, Thorac Cardiovasc Surg, 35, 87, 10.1055/s-2007-1020203 Langenburg SE, Buchanan SA, Blackbourne LH et al. Predicting survival after coronary revascularization for ischemic cardiomyopathy. Ann Thorac Surg 1995;60:1193–1196; discussion 1196–1197. Cook, 1998, Influence of the preoperative signal-averaged electrocardiogram on left ventricular function after coronary artery bypass graft surgery in patients with left ventricular dysfunction. The CABG Patch Trial, Am J Cardiol, 82, 285, 10.1016/S0002-9149(98)00335-X